The GeoTeam® participated in the China-Biotics (OTC:CHBT) 2009 second quarter conference call.
Notable Conference Call Highlights:
- Expects full year fiscal 2010 revenues to grow at least 50% to $81.3 million
- As the stock may be perceived to be currently "undervalued", investors voiced concerns over dilution related to the potential issuance of shares to complete future acquisitions. The Company did a thorough job addressing this concern, implying the possibility of using cash over stock to complete an acquisition. Furthermore, if shares were issued there is still a good chance that a transaction will be accretive to earnings per share.
Disclosure: Long CHBT